- Home
- MOGO vs DYAI Comparison
MOGO vs DYAI Comparison
Compare MOGO & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- DYAI
- Stock Information
- Founded
- MOGO 2003
- DYAI 1979
- Country
- MOGO Canada
- DYAI United States
- Employees
- MOGO N/A
- DYAI N/A
- Industry
- MOGO
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MOGO
- DYAI Health Care
- Exchange
- MOGO Nasdaq
- DYAI Nasdaq
- Market Cap
- MOGO 25.1M
- DYAI 29.6M
- IPO Year
- MOGO N/A
- DYAI 2004
- Fundamental
- Price
- MOGO $1.25
- DYAI $1.00
- Analyst Decision
- MOGO Strong Buy
- DYAI Strong Buy
- Analyst Count
- MOGO 1
- DYAI 1
- Target Price
- MOGO $4.00
- DYAI $6.00
- AVG Volume (30 Days)
- MOGO 167.6K
- DYAI 38.9K
- Earning Date
- MOGO 08-07-2025
- DYAI 08-12-2025
- Dividend Yield
- MOGO N/A
- DYAI N/A
- EPS Growth
- MOGO N/A
- DYAI N/A
- EPS
- MOGO N/A
- DYAI N/A
- Revenue
- MOGO $28,873,274.00
- DYAI $3,554,344.00
- Revenue This Year
- MOGO $59.16
- DYAI $22.56
- Revenue Next Year
- MOGO $6.17
- DYAI $30.95
- P/E Ratio
- MOGO N/A
- DYAI N/A
- Revenue Growth
- MOGO 0.62
- DYAI 57.59
- 52 Week Low
- MOGO $0.74
- DYAI $0.91
- 52 Week High
- MOGO $2.73
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- MOGO 49.85
- DYAI 49.34
- Support Level
- MOGO $1.15
- DYAI $0.95
- Resistance Level
- MOGO $1.31
- DYAI $1.06
- Average True Range (ATR)
- MOGO 0.07
- DYAI 0.06
- MACD
- MOGO -0.01
- DYAI 0.01
- Stochastic Oscillator
- MOGO 45.45
- DYAI 56.67
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.